Production of Anti-melanogenic Glucosides via Molecular Docking-guided Biotransformation of p-hydroxyphenethyl anisate
Applied Biochemistry and Biotechnology · 2026-12 · 198 (12) · 11187-11212
DOI: 10.1007/s12010-026-05917-1 ↗At a glance
Journal article in Applied Biochemistry and Biotechnology, published online on 2026-09-10. Written by Te-Sheng Chang and 8 co-authors. Institution: Department of Biological Sciences and Technology, National University of Tainan, Tainan, Taiwan. Major MEDLINE topics: Molecular Docking Simulation, Glucosides, Melanins. 73 references. Funded by: National Science and Technology Council.
Abstract (original language)
p-Hydroxyphenethyl anisate (HP) has been identified as a natural compound with whitening activity in melanoma cells and zebrafish. Considering that glycosylation can enhance the solubility, stability, and bioactivity of natural products, we investigated whether HP could serve as a substrate for glycosylation enzymes. Molecular docking predicted favorable interactions between HP and amylosucrase as well as glycosyltransferases, suggesting the potential formation of α- and β-glucosides. Enzymatic reactions confirmed the production of phenethylanisate-4'-O-α-glucoside (HP-α-glc) and phenethylanisate-4'-O-β-glucoside (HP-β-glc). The structures were validated by mass spectrometry, enzymatic digestion (HP-α-glc), or nuclear magnetic resonance spectroscopy (HP-β-glc). Biological evaluation revealed that both glucosides suppressed melanogenesis in murine B16-F1 melanoma cells at non-cytotoxic concentrations. Mechanistic studies demonstrated that HP-β-glc not only inhibited tyrosinase activity but also downregulated the expression of the microphthalmia-associated transcription factor (MITF) and tyrosinase at both the protein and mRNA levels, thereby attenuating melanogenesis through transcriptional regulation. Consistently, in vivo assays demonstrated that HP-β-glc effectively inhibited pigmentation in zebrafish embryos without inducing developmental toxicity, and its effect was comparable to that of the positive control, raspberry ketone. These findings highlight the enzymatic glycosylation of HP as a viable strategy to generate bioactive derivatives with improved functional properties. In particular, HP-β-glc retains the anti-melanogenic activity of HP, providing mechanistic evidence and preclinical validation for its potential application as a safe and effective skin-whitening agent.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biological Sciences and Technology, National University of Tainan, Tainan, Taiwan.
- Department of Food Science, National Quemoy University, Kinmen, Taiwan.
- Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
- Biodiversity Research Center, Academia Sinica, Taipei, Taiwan.
- Department of Biological Sciences and Technology, National University of Tainan, Tainan, Taiwan. hting@mail.nutn.edu.tw.
Funding
- National Science and Technology Council
Cite
APA
Chang, T. S., Wu, J. Y., Ding, H. Y., Cho, S. C., Wang, T. Y., Tsao, C. C., Chen, J. Y., Wu, C. Y., & Ting, H. J. (2026). Production of Anti-melanogenic Glucosides via Molecular Docking-guided Biotransformation of p-hydroxyphenethyl anisate. Applied Biochemistry and Biotechnology, 198(12), 11187-11212. https://doi.org/10.1007/s12010-026-05917-1
Vancouver
Chang TS, Wu JY, Ding HY, Cho SC, Wang TY, Tsao CC, et al. Production of Anti-melanogenic Glucosides via Molecular Docking-guided Biotransformation of p-hydroxyphenethyl anisate. Applied Biochemistry and Biotechnology. 2026;198(12):11187-11212. doi:10.1007/s12010-026-05917-1
BibTeX
@article{Chang2026,
author = {Chang, Te-Sheng and Wu, Jiumn-Yih and Ding, Hsiou-Yu and Cho, Shu-Chi and Wang, Tzi-Yuan and Tsao, Che-Chia and Chen, Jou-Yi and Wu, Chien-Yu and Ting, Huei-Ju},
title = {Production of Anti-melanogenic Glucosides via Molecular Docking-guided Biotransformation of p-hydroxyphenethyl anisate},
journal = {Applied Biochemistry and Biotechnology},
year = {2026},
volume = {198},
number = {12},
pages = {11187--11212},
doi = {10.1007/s12010-026-05917-1}
}
EUVIMED